Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Dec 9, 2025 3:59:54 PM EST

19.56USD-1.659%(-0.33)568,033

19.52Bid 19.55Ask 0.03Spread

Pre-market

Dec 9, 2025 9:27:30 AM EST

19.60USD-1.458%(-0.29)7,128

After-hours

Dec 9, 2025 4:33:30 PM EST

19.46USD-0.511%(-0.10)2,006

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

230.17M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

785,126

Avg. Vol. 30 Day

775,074

Employees

Market Cap

230,172,513

Shares Out.

11,776,542

On/Off Exchange

42%/58%

6 Month Beta

3.63

1 Year Beta

0.98

2 Year Beta

1.19

3 Year Beta

1.16

52 Week Low

6.76

52 Week High

130.00

SMA50

18.90

SMA200

26.54

1 Week

+25.93%

1 Month

+16.06%

3 Month

-24.30%

6 Month

-50.14%

1 Year

+4.30%

2 Year

-98.47%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $19.56, and today's volume is 568,033. TNXP is down -1.659% today. The 30 day average volume is 775,074. TNXP market cap is 230.17M with 11,776,542 shares outstanding.